Vitamin D downregulates the IL-23 receptor pathway in human mucosal group 3 innate lymphoid cells
- 1 January 2018
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 141 (1) , 279-292
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse modelJournal of Experimental Medicine, 2013
- The Vitamin D Receptor and T Cell FunctionFrontiers in Immunology, 2013
- IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestineNature, 2012
- The sva package for removing batch effects and other unwanted variation in high-throughput experimentsBioinformatics, 2012
- The Aryl Hydrocarbon Receptor Regulates Gut Immunity through Modulation of Innate Lymphoid CellsImmunity, 2012
- Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signalingInternational Immunology, 2011
- Identity, regulation and in vivo function of gut NKp46+RORγt+ and NKp46+RORγt− lymphoid cellsThe EMBO Journal, 2011
- Transcription factor IRF8 directs a silencing programme for TH17 cell differentiationNature Communications, 2011
- IL-23–responsive innate lymphoid cells are increased in inflammatory bowel diseaseJournal of Experimental Medicine, 2011
- Expansion of human NK-22 cells with IL-7, IL-2, and IL-1β reveals intrinsic functional plasticityProceedings of the National Academy of Sciences, 2010